Efficacy and adverse effect profile of vortioxetine in major depressive disorder: A meta-analysis
Published online on October 08, 2025
Abstract
Journal of Psychopharmacology, Volume 39, Issue 12, Page 1365-1377, December 2025.
Background:Major depressive disorder (MDD) is a globally prevalent condition associated with significant morbidity and cognitive dysfunction. Vortioxetine, a novel antidepressant with multimodal serotonergic activity, has shown potential advantages over ...
Background:Major depressive disorder (MDD) is a globally prevalent condition associated with significant morbidity and cognitive dysfunction. Vortioxetine, a novel antidepressant with multimodal serotonergic activity, has shown potential advantages over ...